CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Yunnan Baiyao Group Co., Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Yunnan Baiyao Group Co., Ltd
222 Er' huan Xi Road
Phone: +86 87166324159p:+86 87166324159 KUNMING, YUN  650500  China Ticker: 000538000538
Business Summary
Yunnan Baiyao Group Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in four businesses. The pharmaceutical business is mainly engaged in the research, development and production of Yunnan Baiyao series, natural specialty brand traditional Chinese medicine and Panax notoginseng plant supplement products. The health products business is mainly engaged in the production and sales of toothpaste, oral care and Yangyuanqing anti-hair loss products. The traditional Chinese medicine resources business is mainly engaged in the production and sales of Panax notoginseng series, brand medicinal materials, raw material extracts, traditional Chinese medicine pieces and health food groups. Yunnan Pharmaceutical Co., Ltd is mainly engaged in pharmaceutical commercial distribution business. The Company mainly conducts its businesses in the domestic market.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
0139 Field crops, except cash grains, not elsewhere classified
2841 Soap and other detergents, except specialty cleaners
8731 Commercial physical and biological research
7011 Hotels and motels

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board WenxueZhang 60 2/23/2024 2/23/2024
President, Chief Executive Officer, Director MingDong 47 2/23/2024 3/3/2021
Chief Financial Officer JiaMa 47 6/1/2022 6/1/2022
12 additional Officers and Directors records available in full report.

Business Names
Business Name
000538
Yunnan Baiyao Group Co., Ltd
Yunnan Baiyao Group Co.,Ltd

General Information
Number of Employees: 8,834 (As of 12/31/2023)
Outstanding Shares: 1,796,862,549 (As of 12/31/2023)
Shareholders: 199,821
Stock Exchange: SHE
Fax Number: +86 87166324169


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024